ArticleInternational journal of hematology2018

CBL mutation and MEFV single-nucleotide variant are important genetic predictors of tumor reduction in glucocorticoid-treated patients with chronic myelomonocytic leukemia.

Junichi Watanabe et al.PubMed ↗Publisher ↗

No numbers read from the abstract.